WED-441 - A novel orally available type IV autotaxin inhibitor, IOA-289, ameliorates steatosis and fibrosis in a preclinical model of non-alcoholic steatohepatitis

Marit ten Hove; Giusy Di Conza; Karolina Niewola; Marcel Deken; Lars van der Veen; Ruchi Bansal

doi:10.1016/S0168-8278(23)02176-1

WED-441 - A novel orally available type IV autotaxin inhibitor, IOA-289, ameliorates steatosis and fibrosis in a preclinical model of non-alcoholic steatohepatitis

Marit ten Hove, Giusy Di Conza, Karolina Niewola, Marcel Deken, Lars van der Veen, Ruchi Bansal

Medical Cell Biophysics

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	S761-S762
Journal	Journal of hepatology
Volume	78
Issue number	Suppl. 1
DOIs	https://doi.org/10.1016/S0168-8278(23)02176-1
Publication status	Published - 1 Jun 2023
Event	EASL Congress 2023 - Vienna, Austria Duration: 21 Jun 2023 → 24 Jun 2023

Access to Document

10.1016/S0168-8278(23)02176-1

Cite this

@article{fb7a48a468b544d3bb68cc89b995f95a,

title = "WED-441 - A novel orally available type IV autotaxin inhibitor, IOA-289, ameliorates steatosis and fibrosis in a preclinical model of non-alcoholic steatohepatitis",

author = "\{ten Hove\}, Marit and \{Di Conza\}, Giusy and Karolina Niewola and Marcel Deken and \{van der Veen\}, Lars and Ruchi Bansal",

year = "2023",

month = jun,

day = "1",

doi = "10.1016/S0168-8278(23)02176-1",

language = "English",

volume = "78",

pages = "S761--S762",

journal = "Journal of hepatology",

issn = "0168-8278",

publisher = "Elsevier B.V.",

number = "Suppl. 1",

note = "EASL Congress 2023 ; Conference date: 21-06-2023 Through 24-06-2023",

}

WED-441 - A novel orally available type IV autotaxin inhibitor, IOA-289, ameliorates steatosis and fibrosis in a preclinical model of non-alcoholic steatohepatitis. / ten Hove, Marit; Di Conza, Giusy; Niewola, Karolina et al.
In: Journal of hepatology, Vol. 78, No. Suppl. 1, 01.06.2023, p. S761-S762.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - WED-441 - A novel orally available type IV autotaxin inhibitor, IOA-289, ameliorates steatosis and fibrosis in a preclinical model of non-alcoholic steatohepatitis

AU - ten Hove, Marit

AU - Di Conza, Giusy

AU - Niewola, Karolina

AU - Deken, Marcel

AU - van der Veen, Lars

AU - Bansal, Ruchi

PY - 2023/6/1

Y1 - 2023/6/1

U2 - 10.1016/S0168-8278(23)02176-1

DO - 10.1016/S0168-8278(23)02176-1

M3 - Meeting Abstract

SN - 0168-8278

VL - 78

SP - S761-S762

JO - Journal of hepatology

JF - Journal of hepatology

IS - Suppl. 1

T2 - EASL Congress 2023

Y2 - 21 June 2023 through 24 June 2023

ER -